Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market

Comments · 28 Views

The “Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market” is likely to grow at a CAGR of around 23.6% during the forecast period, i.e., 2021-26, says MarkNtel Advisors.

In their study report, MarkNtel Advisors integrates an extensive detail-driven examination of the industry with a thorough understanding of the broad dynamics of the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market. This analysis demonstrates the various factors, including market expansion drivers, restraints, opportunities, challenges, major trends, and recent developments.

Estimates for the forecast period were created using data from the report's historical years (2016-2019) and base year (2020). Our researchers assembled trustworthy, unbiased, and accurate data for the study in order to inform investors about changes in the industry and predictions for the future. This study gives the leading companies the information they need to make strategic decisions about their investments in the upcoming years because the industry is dynamic and highly fragmented.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])-

Key Provisions of the Report:

The study report bases its parameters on the following parameters and integrates historical data, current trends and developments, and competition plans across several geographic segments.

  • Profits and Gross Margins
  • Decline in Demand
  • Possibilities for Investment and Generating Income
  • Business Plans and Shares
  • Identification of Key Actors
  • Leading Regions
  • Developments and Trends, Among other Things

Business Dynamics:

The Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market research includes several segmentations and a regional landscape, as well as important factors that have a favourable impact on market growth. This section includes data on demand, sales, revenue, and other factors for various segments in various locales. This section informs the stakeholders to make educated decisions in the future by providing insights on the current trends, developments, plans for revenue generation and visibility of the business, profit yields, and other elements.

Sectorial Analysis of the Industry:

The Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market can be divided into the following segments due to its extreme fragmentation:

Marketplace Dividend, By Component



Marketplace Dividend, By Application

-Data Aggregation and Analysis

-Clinical Trials

-Drug Design

-Drug Characterization

-Biomarker Research

Marketplace Dividend, By Therapeutic Application


-Cardiovascular Disease

-Nervous System Disease

-Respiratory Disorder

-Metabolic Disorder

-Immunologic Disease

-Infectious Disease


Marketplace Dividend, By End-User

-Biopharmaceutical Industry

-Contract Research Organization (CROs)

-Academic Institutes and Research Centers

Marketplace Dividend, By Region

-North America

-South America



-Middle East Africa

Browse Full Report Description (Research Methodology + Table of Content + Infographics)-

Competitive Research:

The Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market study includes a thorough analysis of the evolving interface, strategies, and sustainability techniques of the leading players by meticulously profiling each business. The main goal is to compile all the data affecting the following factors for industry expansion:

  • Investment values fluctuate
  • A description of the business
  • History and business plan
  • Expansion of the product/service portfolio
  • Where the players are located

The paper also discusses the tactics used by competitors to preserve their market leadership and generate greater profits while growing their firm internationally. In this research, each organisation is profiled based on the following criteria:

  • Current trends and recent advancements
  • Performance metrics
  • Goods/Services provided
  • SWOT and risk analysis

The prominent companies profiled in the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market report are:

-Accutar Biotechnology


-Atomwise Inc.

-AiCure, LLC

-Berg LLc

-Cloud Pharmaceuticals


-Cyclica Inc.

-Symphony Innovations

-GNS Healthcare


Personalized Services:

MarkNtel Advisors provide stakeholders and investors with customised reports that address all pertinent issues in a thorough, objective, accurate, and trustworthy manner. Its main objective is to give the participants the tools they need to gather all the facts underpinning the market's potential in the future and to formulate wise plans of action.

Custom Requirements can be requested for this Report [Customization Available]-

About MarkNtel Advisors-

MarkNtel Advisors is a leading research, consulting, data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, individuals, among others.

Our specialization in niche industries emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing forecasting, trend analysis, among others, for 15 diverse industrial verticals.

Using such information, our clients can identify attractive investment opportunities strategize their moves to yield higher ROI (Return of Interest) through an early mover advantage with top-management approaches.

We understand the mounting diverse needs of our clients. Hence, our analysts focus on emerging industries to provide services that fulfil their assessment of the current future industry potential, identify white spaces hotspots, venture into new geographies or business segments in the future.

Contact us at for any inquiries:

Email: [email protected]

Call - +1 604 800 2671, +91 120 4311129